ABBV-950 + BOTOX + Placebo for ABBV-950
Phase 1Terminated 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Upper Limb Spasticity
Conditions
Upper Limb Spasticity
Trial Timeline
Jan 12, 2024 → Jun 2, 2024
NCT ID
NCT05956509About ABBV-950 + BOTOX + Placebo for ABBV-950
ABBV-950 + BOTOX + Placebo for ABBV-950 is a phase 1 stage product being developed by AbbVie for Upper Limb Spasticity. The current trial status is terminated. This product is registered under clinical trial identifier NCT05956509. Target conditions include Upper Limb Spasticity.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05956509 | Phase 1 | Terminated |
Competing Products
20 competing products in Upper Limb Spasticity